# Table 1 Sociodemographic, clinical characteristics and HPV profile of cases by histological grade and age group (Guadeloupe, 2014–2016)

Overall

Invasive cancers

p

< 40 years

41–50 years

> 50 years

p

n = 213

n = 184

n = 29

n = 111

n = 56

n = 46

Year of diagnosis, n(%)

0.53

0.25

2014

98 (46)

82 (45)

16 (55)

44 (40)

27 (48)

27 (59)

2015

50 (23)

45 (24)

5 (17)

29 (26)

14 (25)

7 (15)

2016

65 (31)

57 (31)

8 (28)

38 (34)

15 (27)

12 (26)

HPV status, n(%)

0.67

0.33

HPV-

12 (6)

10 (5)

2 (7)

6 (5)

5 (9)

1 (2)

HPV+

201 (94)

174 (95)

27 (93)

105 (95)

51 (91)

45 (98)

n = 188

n = 162

n = 26

n = 97

n = 48

n = 43

Profile of infectiona, n(%)

0.002

0.99

1 virus

34 (18.1)

32 (19.7)

2 (7.7)

18 (18.6)

9 (18.7)

7 (16.3)

2 to 3 virus

66 (35.1)

49 (30.2)

17 (65.4)

33 (34.0)

17 (35.4)

16 (37.2)

>  3 virus

88 (46.8)

81 (50.0)

7 (26.9)

46 (47.4)

22 (45.8)

20 (46.5)

HPV oncogenicity riska, n(%)

High-risk

183 (91)

157 (91)

26 (93)

0.77

93 (84)

48 (86)

42 (91)

0.48

Probable High risk

104 (52)

90 (52)

14 (50)

0.95

52 (47)

27 (48)

25 (54)

0.69

Low risk and others

101 (51)

84 (49)

17 (61)

0.92

52 (47)

24 (43)

25 (54)

0.50

HR-HPV in combinationa, n(%)

0.6

0.7

No HR

5 (2.7)

5 (3.1)

0

4 (4.1)

0

1 (2.3)

1 HR

58 (30.8)

48 (29.6)

10 (38.5)

28 (28.9)

17 (35.4)

13 (30.2)

2–3 HR

91 (48.4)

80 (49.4)

11 (42.3)

45 (46.4)

23 (47.9)

23 (53.5)

> 3 HR

34 (18.1)

29 (17.9)

5 (19.2)

20 (20.6)

8 (16.7)

6 (13.9)

1. a Proportions are calculated after excluding positive cases with missing data for genotypes and negative cases